Jeffrey E. states that the drug requires a shot, is not a pill, and has no known long-term effects so far.
This document is an email from Jeffrey Epstein to Sultan Bin Sulayem on July 24, 2015, discussing a new, expensive cholesterol-lowering drug called Praluent. Epstein's email is a reply to an inquiry from Sulayem, who had forwarded a Forbes article announcing the FDA's approval of the drug, which is administered as a shot.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein communication